Tier 1 — must know
Canine
Hematology
Critical care
Immune-mediated hemolytic anemia
Hemolytic anemia · oxygen-delivery triage + immune-destruction evidence + thromboembolism thinking
⏱ 2–3 min read · Topic 6 of 141
4
Practice Qs
4
Traps
High
Exam freq.
—
Your status
Study step
High-yield takeaways
- Recognize the classic presentation, then narrow the case using signalment, timeline, exam findings, diagnostics, and response to treatment.
- Use the decision framework, traps, differentials, and related questions to rehearse NAVLE-style next-best-step reasoning.
- This educational study page is not a clinical protocol; confirm patient-specific decisions with current references and clinician judgment.
30-second revision
Classic patternAnemia + hemolysis + immune-destruction clues
Best cluesSpherocytes and persistent saline agglutination
StabilizeTransfuse if oxygen delivery is poor
Core therapyImmunosuppression after sampling
MonitorPlatelets, respiratory signs, thrombosis risk
Think broaderSearch for secondary trigger
Critical trapRegeneration alone does not prove IMHA
Exam core — read this first
Classic pattern → anemia plus hemolysis evidence and immune-destruction clues
If unstable → protect oxygen delivery first; packed RBC transfusion is supportive, not curative
Core therapy → immunosuppression after appropriate sampling, plus secondary-trigger search
Do not forget → thromboembolism risk and platelet status change the urgency of monitoring
Emergency Triage Alert
Oxygen Delivery Comes First
A crashing IMHA dog is a stabilization question before it is a perfect-diagnostics question. Support perfusion and oxygen delivery while collecting the minimum useful evidence for immune-mediated hemolysis.
Thromboembolism Risk
High-Risk Monitoring
IMHA is not just an anemia problem. Respiratory changes, platelet status, and thromboembolism risk belong in the hospitalization plan.
Clinical mechanism — only what matters
Antibody-mediated RBC destruction → extravascular hemolysis is common; intravascular hemolysis is possible
Falling red cell mass → poor oxygen delivery, tachycardia, weakness, collapse
Inflammation + hemolysis → hypercoagulability and thromboembolism risk
Boards focus on recognizing hemolysis, proving immune destruction efficiently, and stabilizing the dangerous anemia.
Pattern recognition
Core pattern
Pale or icteric dogHemolysis evidenceSpherocytes / persistent agglutination
Supporting clues
TachycardiaWeakness / collapseHyperbilirubinemiaPigmenturia possibleFever possibleRegeneration may be delayed
NAVLE trigger: Hemolysis plus immune-destruction evidence should move IMHA above blood loss anemia, even before every send-out test returns.
Decision core — what NAVLE actually asks
Critically anemic or collapsing patient
→ Stabilize oxygen delivery and transfuse if clinically indicated while continuing the diagnostic workup
Hemolysis + immune-destruction evidence
→ Start immunosuppressive therapy after appropriate sampling; do not wait for a perfect test panel in a crashing dog
Regeneration absent early
→ Do not rule out IMHA solely because reticulocytosis has not developed yet; interpret timing and marrow response together
Confirmed or strongly suspected IMHA
→ Add thromboembolism monitoring/prevention thinking and search for secondary triggers
Key interpretation
PCV / HCT
↓ Low
Often severe
Hemolysis
Present
Hyperbilirubinemia, hemoglobinemia, or pigmenturia support it
Smear
Spherocytes
High-yield immune-destruction clue in dogs
Agglutination
Persists in saline
True autoagglutination supports IMHA
Reticulocytes
Often ↑
May lag early or with marrow involvement
Platelets
Check carefully
Concurrent thrombocytopenia changes the case framing
⚠ NAVLE does not require you to wait for a Coombs test before stabilizing a crashing dog with strong smear/agglutination and hemolysis evidence.
Treatment
Stabilize
Packed RBC transfusion when clinical oxygen delivery is inadequate
Transfusion buys time; it does not stop immune destruction.
Core Rx
Prednisone-based immunosuppression after appropriate sampling
This is the central primary-IMHA treatment answer unless the stem clearly asks about refractory disease.
Also
Antithrombotic plan + secondary-trigger search
Tick-borne disease, drugs, neoplasia, and inflammatory disease can change the plan.
Pharmacology pearls
Prednisone
Logic: Immunosuppression
Board Pearl: The common first-line board answer for primary canine IMHA.
Clopidogrel
Logic: Thromboprophylaxis
Board Pearl: Used in many IMHA plans because thromboembolism is a major mortality concern.
Packed RBCs
Logic: Support oxygen delivery
Board Pearl: Transfusion supports the patient while immunosuppression begins to work.
NAVLE traps — where students lose marks
Do not call every regenerative anemia IMHA
Blood loss can regenerate too. You need hemolysis plus immune-destruction clues.
Do not wait for ideal diagnostics before stabilizing
Packed RBC support may be the immediate lifesaving step in a critically anemic dog.
Do not treat agglutination and rouleaux as the same finding
True autoagglutination persists after saline dilution; rouleaux disperses.
Do not forget thromboembolism and secondary triggers
A shallow answer stops at anemia; a stronger answer manages the whole syndrome.
Regeneration can lag
Early or severe cases may not look strongly regenerative at the first CBC, so use the whole hemolysis pattern.
Do not forget crossmatch/transfusion planning
A crashing anemia stem tests oxygen delivery and blood-product safety, not just the diagnosis name.
Differentials — how to separate these on NAVLE
Fast separator: IMHA needs hemolysis plus immune-destruction evidence. The board contrasts it with hemorrhage, oxidative hemolysis, infectious hemolysis, and nonregenerative anemia.
| Disease | Regenerative? | Hemolysis clues | Key separator |
|---|---|---|---|
| IMHA | Often yes | Spherocytes / persistent agglutination | Hemolysis plus immune-destruction pattern |
| Acute blood loss | Yes after delay | No | Hemorrhage clues without icteric/hemolytic pattern |
| Zinc/onion oxidative hemolysis | Yes | Hemolysis yes | Exposure history with Heinz bodies/eccentrocytes |
| Babesia / infectious hemolysis | Yes | Hemolysis yes | Travel, tick exposure, organism/PCR context |
| Nonregenerative anemia | No or weak | Usually no | Marrow, chronic disease, or early/pre-regenerative timing |
Clinical application tools
These tools support stabilization reference work around a critically anemic patient.
Related questions
Pre-built NAVLE-style · Immune-mediated hemolytic anemia
0 / 0
A dog is weak, tachycardic, and mildly icteric. CBC shows severe anemia, chemistry shows hyperbilirubinemia, and the smear has many spherocytes with agglutination that persists after saline dilution. Which diagnosis is most likely?
A dog with suspected IMHA is collapsing with pale mucous membranes, tachycardia, weak pulses, and a critically low PCV. What is the best immediate management principle?
Which finding most strongly supports immune-mediated hemolysis over simple blood loss anemia?
Which therapy is most central to initial treatment of primary canine IMHA?